146
Participants
Start Date
April 1, 2025
Primary Completion Date
October 1, 2026
Study Completion Date
December 1, 2026
Catheter ablation plus medication
All patients will receive atrial fibrillation catheter ablation. They also should receive guideline-directed medical therapy, anticoagulation, and rate control with medications according to the guidelines.
Medication
Patients will receive guideline-directed medical therapy, anticoagulation, and rate control according to the guidelines for the management of AF and heart failure.
(ELEVATE-AF X) experimental group
Subsequent ablations may be considered for patients with recurrence,and the medical therapy for ELEVATE-AF X is identical to that of the ELEVATE-AF trial.
(ELEVATE-AF X) control group
All patients could receive catheter ablation if the procedure is needed, and the medical therapy for ELEVATE-AF X is identical to that of the ELEVATE-AF trial.
Beijing Anzhen Hospital, Capital Medical University, Beijing
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Collaborators (1)
Abbott
INDUSTRY
Beijing Anzhen Hospital
OTHER